Background illustration for clinical trials search

Paid Clinical Trials Madison

Discover 514 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

for
Advanced Esophageal Adenocarcinoma,
Location: Madison WI, Oconomowoc WI, Summit WI, Rockford IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06203600

Phase2, Phase3, Recruiting
Active & Responsive

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

for
Alcohol Use Disorder
Location: Madison WI, Hines IL, Minneapolis MN, Ann Arbor MI,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT07218354

Phase3, Recruiting
Active & Responsive

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

for
Metastatic Castrate Resistant Prostate Cancer,
Location: Madison WI, Minneapolis MN, Ann Arbor MI,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT04038502

Phase2, Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Madison WI, Milwaukee WI, Chicago IL, Iowa City IA,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase2, Phase3, Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for
Breast Neoplasms
Location: Madison WI, Chicago IL, St Louis MO, Detroit MI,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312176

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Madison WI, Chicago IL, Arlington Heights IL, Peoria IL,
Sponsor: Immuneering Corporation

Sex: All

Age: 18+

Code: NCT07562152

Phase3, Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Madison WI, Chicago IL, Indianapolis IN, Ann Arbor MI,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase1, Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Madison WI, Rochester MN, Minneapolis MN, St Louis MO,
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase1, Phase2, Recruiting
Active & Responsive

UWCCC Molecular Tumor Board Registry

for
Hematologic Neoplasms, Solid Neoplasm
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT03023202

Recruiting
Active & Responsive

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

for
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia,
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 0 - 21

Code: NCT02508038

Phase1, Recruiting
Active & Responsive

Biomarkers to Detect Endocrine Therapy Resistance

for
Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT06067503

Phase2, Recruiting
Active & Responsive

Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma

for
Esophageal Adenocarcinoma, Gastric Adenocarcinoma
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT04150640

Phase2, Recruiting
Active & Responsive

Study of 18F-FFNP Breast PET/MRI

for
Breast Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: Female

Age: 18+

Code: NCT06086704

Phase2, Recruiting
Active & Responsive

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

for
Glioblastoma, IDH-Wildtype
Location: Madison WI, West Bend WI, Menomonee Falls WI,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT06319027

Phase2, Recruiting
Active & Responsive

Clinical Evaluation of a Treatment Planning Software and Oncology Information System for Proton Therapy

for
Proton Therapy
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT07759999

Recruiting
Active & Responsive

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Madison WI, Columbus OH, Tucson AZ
Sponsor: University of Wisconsin, Madison

Sex: Male

Age: 18+

Code: NCT05521698

Phase1, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Location: Madison WI, Milwaukee WI, Iowa City IA, Rochester MN,
Sponsor: C4 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07284758

Phase2, Recruiting
Active & Responsive

Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers

for
Ovarian Cancer, Cognitive Change
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: Female

Age: 18+

Code: NCT07125209

Recruiting
Active & Responsive

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

for
Prostate Cancer,
Location: Madison WI, Evanston IL, Chicago Ridge IL,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT07005154

Phase2, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Madison WI, Chicago IL, Minneapolis MN, Indianapolis IN,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting